Literature DB >> 23515427

Limited resection for duodenal gastrointestinal stromal tumors: Surgical management and clinical outcome.

Jens Hoeppner1, Birte Kulemann, Goran Marjanovic, Peter Bronsert, Ulrich Theodor Hopt.   

Abstract

AIM: To analyze our experience in patients with duodenal gastrointestinal stromal tumors (GIST) and review the appropriate surgical approach.
METHODS: We retrospectively reviewed the medical records of all patients with duodenal GIST surgically treated at our medical institution between 2002 and 2011. Patient files, operative reports, radiological charts and pathology were analyzed. For surgical therapy open and laparoscopic wedge resections and segmental resections were performed for limited resection (LR). For extended resection pancreatoduodenectomy was performed. Age, gender, clinical symptoms of the tumor, anatomical localization, tumor size, mitotic count, type of resection resectional status, neoadjuvant therapy, adjuvant therapy, risk classification and follow-up details were investigated in this retrospective study.
RESULTS: Nine patients (5 males/4 females) with a median age of 58 years were surgically treated. The median follow-up period was 45 mo (range 6-111 mo). The initial symptom in 6 of 9 patients was gastrointestinal bleeding (67%). Tumors were found in all four parts of the duodenum, but were predominantly located in the first and second part of the duodenum with each 3 of 9 patients (33%). Two patients received neoadjuvant medical treatment with 400 mg imatinib per day for 12 wk before resection. In one patient, the GIST resection was done by pancreatoduodenectomy. The 8 LRs included a segmental resection of pars 4 of the duodenum, 5 wedge resections with primary closure and a wedge resection with luminal closure by Roux-Y duodeno-jejunostomy. One of these LRs was done minimally invasive; seven were done in open fashion. The median diameter of the tumors was 54 mm (14-110 mm). Using the Fletcher classification scheme, 3/9 (33%) tumors had high risk, 1/9 (11%) had intermediate risk, 4/9 (44%) had low risk, and 1/9 (11%) had very low risk for aggressive behaviour. Seven resections showed microscopically negative transsection margins (R0), two showed positive margins (R1). No patient developed local recurrence during follow-up. The one patient who underwent pancreatoduodenectomy died due to progressive disease with hepatic metastasis but without evidence of local recurrence. Another patient died in complete remission due to cardiac disease. Seven of the nine patients are alive disease-free.
CONCLUSION: In patients with duodenal GIST, limited surgical resection with microscopically negative margins, but also with microscopically positive margins, lead to very good local and systemic disease-free survival.

Entities:  

Keywords:  Duodenum; Gastrointestinal stromal tumor; Limited resection; Surgery; Survival

Year:  2013        PMID: 23515427      PMCID: PMC3600567          DOI: 10.4240/wjgs.v5.i2.16

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  16 in total

Review 1.  Adjuvant and neoadjuvant therapy for primary GIST.

Authors:  Burton L Eisenberg; Kerrington D Smith
Journal:  Cancer Chemother Pharmacol       Date:  2010-11-30       Impact factor: 3.333

2.  Gastrointestinal stromal tumor involving the second and third portion of the duodenum: treatment by partial duodenectomy and Roux-en-Y duodenojejunostomy.

Authors:  Brian K P Goh; Pierce K H Chow; Hock-Soo Ong; Wai-Keong Wong
Journal:  J Surg Oncol       Date:  2005-09-15       Impact factor: 3.454

3.  Presentation and management of gastrointestinal stromal tumors of the duodenum.

Authors:  Robert D Winfield; Steven N Hochwald; Stephen B Vogel; Alan W Hemming; Chen Liu; William G Cance; Stephen R Grobmyer
Journal:  Am Surg       Date:  2006-08       Impact factor: 0.688

Review 4.  Gastrointestinal stromal tumors: recent advances in understanding of their biology.

Authors:  M Miettinen; M Sarlomo-Rikala; J Lasota
Journal:  Hum Pathol       Date:  1999-10       Impact factor: 3.466

5.  The effect of surgery and grade on outcome of gastrointestinal stromal tumors.

Authors:  J P Pierie; U Choudry; A Muzikansky; B Y Yeap; W W Souba; M J Ott
Journal:  Arch Surg       Date:  2001-04

6.  Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.

Authors:  T Aparicio; V Boige; J-C Sabourin; P Crenn; M Ducreux; A Le Cesne; S Bonvalot
Journal:  Eur J Surg Oncol       Date:  2004-12       Impact factor: 4.424

7.  Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases.

Authors:  Markku Miettinen; Janusz Kopczynski; Hala R Makhlouf; Maarit Sarlomo-Rikala; Hajnalka Gyorffy; Allen Burke; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

Review 8.  Gastrointestinal stromal tumours.

Authors:  E M Connolly; E Gaffney; J V Reynolds
Journal:  Br J Surg       Date:  2003-10       Impact factor: 6.939

Review 9.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

10.  Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.

Authors:  Cristina R Antonescu; Agnes Viale; Lisa Sarran; Sylvia J Tschernyavsky; Mithat Gonen; Neil H Segal; Robert G Maki; Nicholas D Socci; Ronald P DeMatteo; Peter Besmer
Journal:  Clin Cancer Res       Date:  2004-05-15       Impact factor: 12.531

View more
  16 in total

1.  Segmental duodenal resection: indications, surgical techniques and postoperative outcomes.

Authors:  D Dorcaratto; H M Heneghan; B Fiore; F Awan; D Maguire; J Geoghegan; K Conlon; E Hoti
Journal:  J Gastrointest Surg       Date:  2015-01-17       Impact factor: 3.452

2.  Rare cases reports of gastrointestinal stromal tumour (GIST).

Authors:  M Amendolara; S Ramuscello; A Broggiato; A Andreotti; G Stevanato; M Bonfiglio; M Bernardi; D Parini; F Galeotti; M Rizzo
Journal:  G Chir       Date:  2014 May-Jun

3.  Surgery for Duodenal Gastrointestinal Stromal Tumors: A Single-Center Experience.

Authors:  Ping Chen; Tianqiang Song; Xin Wang; Hongyuan Zhou; Ti Zhang; Qiang Wu; Dalu Kong; Yunlong Cui; Huikai Li; Qiang Li
Journal:  Dig Dis Sci       Date:  2017-09-15       Impact factor: 3.199

4.  Side-to-side duodenojejunostomy after resection of third and fourth duodenal portions with pancreatic preservation.

Authors:  Gerardo Blanco-Fernández; Adela Rojas-Holguín; Noelia De-Armas-Conde; Isabel Gallarín-Salamanca; Diego López-Guerra; Isabel Jaén-Torrejimeno
Journal:  Updates Surg       Date:  2020-06-05

5.  A gastrointestinal stromal tumor of the third portion of the duodenum treated by wedge resection: A case report.

Authors:  Fahrettin Acar; Mustafa Sahin; Serdar Ugras; Akın Calisir
Journal:  World J Gastrointest Surg       Date:  2013-12-27

6.  Limited resections for duodenal gastrointestinal stromal tumors and their oncologic outcomes.

Authors:  Jun Chul Chung; Hyung Chul Kim; Sung Mo Hur
Journal:  Surg Today       Date:  2015-04-10       Impact factor: 2.549

7.  Limited Resection Versus Pancreaticoduodenectomy for Duodenal Gastrointestinal Stromal Tumors? Enucleation Interferes in the Debate: A European Multicenter Retrospective Cohort Study.

Authors:  Clément Dubois; Frederiek Nuytens; Hélène Behal; Caroline Gronnier; Gilles Manceau; Maxime Warlaumont; Alain Duhamel; Quentin Denost; Charles Honoré; Olivier Facy; Jean-Jacques Tuech; Guido Tiberio; Cécile Brigand; Jean-Pierre Bail; Ephrem Salame; Bernard Meunier; Jérémie H Lefevre; Muriel Mathonnet; Mohamed Sbai Idrissi; Florence Renaud; Guillaume Piessen
Journal:  Ann Surg Oncol       Date:  2021-04-10       Impact factor: 5.344

8.  Successful treatment of bleeding large duodenal gastrointestinal stromal tumour in a patient under dual antiplatelet therapy after recent drug-eluting coronary stent implantation.

Authors:  Keita Fukuyama; Takahisa Fujikawa; Shoichi Kuramitsu; Akira Tanaka
Journal:  BMJ Case Rep       Date:  2014-04-28

9.  Surgical treatment of gastrointestinal stromal tumors of the duodenum: a literature review.

Authors:  Georgi Popivanov; Mihail Tabakov; George Mantese; Roberto Cirocchi; Irene Piccinini; Vito D'Andrea; Piero Covarelli; Carlo Boselli; Francesco Barberini; Renata Tabola; Ursi Pietro; Davide Cavaliere
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-21

10.  Atypical presentation of gastrointestinal stromal tumor masquerading as a large duodenal cyst: A case report.

Authors:  Ameet Kumar; C K Jakhmola; Shivraj Singh Chauhan; Apoorv Singh
Journal:  Int J Surg Case Rep       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.